Kleer CG - Search Results

1

CCN6 regulates IGF2BP2 and HMGA2 signaling in metaplastic carcinomas of the breast.

McMullen ER, Gonzalez ME, Skala SL, Tran M, Thomas D, Djomehri SI, Burman B, Kidwell KM, Kleer CG. McMullen ER, et al. Among authors: kleer cg. Breast Cancer Res Treat. 2018 Dec;172(3):577-586. doi: 10.1007/s10549-018-4960-2. Epub 2018 Sep 15. Breast Cancer Res Treat. 2018. PMID: 30220054 Free PMC article.

2

Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants.

Kleer CG, van Golen KL, Merajver SD. Kleer CG, et al. Breast Cancer Res. 2000;2(6):423-9. doi: 10.1186/bcr89. Epub 2000 Jul 11. Breast Cancer Res. 2000. PMID: 11250736 Free PMC article. Review.

3

E-cadherin expression in primary carcinomas of the breast and its distant metastases.

Kowalski PJ, Rubin MA, Kleer CG. Kowalski PJ, et al. Among authors: kleer cg. Breast Cancer Res. 2003;5(6):R217-22. doi: 10.1186/bcr651. Epub 2003 Sep 26. Breast Cancer Res. 2003. PMID: 14580257 Free PMC article.

4

WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.

Kleer CG, Zhang Y, Pan Q, Gallagher G, Wu M, Wu ZF, Merajver SD. Kleer CG, et al. Breast Cancer Res. 2004;6(1):R110-5. doi: 10.1186/bcr755. Breast Cancer Res. 2004. PMID: 14696649 Free PMC article.

5

WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer.

Kleer CG, Zhang Y, Pan Q, Merajver SD. Kleer CG, et al. Neoplasia. 2004 Mar-Apr;6(2):179-85. doi: 10.1593/neo.03316. Neoplasia. 2004. PMID: 15140407 Free PMC article.

6

Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy.

Schott AF, Roubidoux MA, Helvie MA, Hayes DF, Kleer CG, Newman LA, Pierce LJ, Griffith KA, Murray S, Hunt KA, Paramagul C, Baker LH. Schott AF, et al. Among authors: kleer cg. Breast Cancer Res Treat. 2005 Aug;92(3):231-8. doi: 10.1007/s10549-005-2510-1. Breast Cancer Res Treat. 2005. PMID: 16155794 Free article.

7

Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.

Pan Q, Bao LW, Kleer CG, Sabel MS, Griffith KA, Teknos TN, Merajver SD. Pan Q, et al. Among authors: kleer cg. Cancer Res. 2005 Sep 15;65(18):8366-71. doi: 10.1158/0008-5472.CAN-05-0553. Cancer Res. 2005. PMID: 16166314

8

RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.

Kleer CG, Griffith KA, Sabel MS, Gallagher G, van Golen KL, Wu ZF, Merajver SD. Kleer CG, et al. Breast Cancer Res Treat. 2005 Sep;93(2):101-10. doi: 10.1007/s10549-005-4170-6. Breast Cancer Res Treat. 2005. PMID: 16187229 Free article.

9

Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis.

Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, Chinnaiyan AM, Kleer CG. Mehra R, et al. Among authors: kleer cg. Cancer Res. 2005 Dec 15;65(24):11259-64. doi: 10.1158/0008-5472.CAN-05-2495. Cancer Res. 2005. PMID: 16357129

10

Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells.

Zhang Y, Pan Q, Zhong H, Merajver SD, Kleer CG. Zhang Y, et al. Among authors: kleer cg. Breast Cancer Res. 2005;7(6):R1080-9. doi: 10.1186/bcr1351. Epub 2005 Nov 8. Breast Cancer Res. 2005. PMID: 16457688 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page